FormDSignal

Longeveron Inc. (LGVN)

1 Item 5.02 filing since 2026-10-14 · 1 with an open seat · roles: CMO. Nasdaq. Pharmaceutical Preparations. State: FL.

ScoreFiledEventRolePersonSeatSummary
472026-10-14DepartureCMOsubscribersOpenLongeveron Inc. (LGVN): CMO Dr. Nataliya Agafonova resigned

Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works